Skip to main content
. Author manuscript; available in PMC: 2022 Jun 27.
Published in final edited form as: Hepatology. 2021 Nov 27;75(4):1026–1037. doi: 10.1002/hep.32143

TABLE 2.

Clinical scores in the management of ALD and AH

Score (reference) Elements Clinical outcome Clinical application and thresholds
DF[70] Serum bilirubin and prothrombin time Survival at 30 days ≥32 high risk of mortality and candidacy for corticosteroids
MELD[71] Serum bilirubin, INR, serum creatinine Survival at 30 and 90 days ≥21 high risk of mortality and candidacy for corticosteroids
ABIC[72] Serum bilirubin, INR, serum creatinine, age of the patient Survival at 90 days and 1 year ≥9 high risk of mortality
≥6.71 intermediate risk
GAHS[73] Serum bilirubin, prothrombin time, serum creatinine, patient’s age, WBC count Survival at 28 and 84 days ≥9 high risk of mortality and candidacy for corticosteroids
Lille[19] Serum bilirubin at days 0 and 7, prothrombin time, serum creatinine, patient’s age, serum albumin 6-month survival with corticosteroid treatment ≥0.45 at day 7; nonresponse to corticosteroids
SALT[60] > 10 drinks per day at initial hospitalization, multiple prior rehabilitation attempts, prior alcohol-related legal issues, and prior illicit substance abuse Sustained alcohol use after LT ≤5 low risk for alcohol relapse after LT

Abbreviations: ABIC, age, bilirubin, INR, creatinine; DF, discriminant function; GAHS, Glasgow alcohol hepatitis score; INR, international normalized ratio; MELD, Model for End-Stage Liver Disease; SALT, sustained alcohol use after liver transplant; and WBC, white blood cell.